HCM
Hutchinson Capital Management Portfolio holdings
AUM
$548M
This Quarter Return
-0.74%
1 Year Return
+12.58%
3 Year Return
+50.43%
5 Year Return
+107.91%
10 Year Return
+193.52%
AUM
$338M
AUM Growth
+$338M
(-3.8%)
Cap. Flow
-$11M
Cap. Flow
% of AUM
-3.25%
Top 10 Holdings %
Top 10 Hldgs %
57.06%
Holding
60
New
1
Increased
8
Reduced
27
Closed
4
Top Buys
| 1 |
Jefferies Financial Group
JEF
|
$9.82M |
| 2 |
Arcos Dorados Holdings
ARCO
|
$7.94M |
| 3 |
American Eagle Outfitters
AEO
|
$1.48M |
| 4 |
General Motors
GM
|
$578K |
| 5 |
NOV
NOV
|
$462K |
Top Sells
| 1 |
Fluor
FLR
|
$10.4M |
| 2 |
HUB.B
HUBBELL INC CL-B
HUB.B
|
$7.45M |
| 3 |
Valero Energy
VLO
|
$7.42M |
| 4 |
Medtronic
MDT
|
$3.84M |
| 5 |
CVS Health
CVS
|
$472K |
Sector Composition
| 1 | Financials | 28.54% |
| 2 | Consumer Discretionary | 20.45% |
| 3 | Industrials | 13.45% |
| 4 | Healthcare | 11.95% |
| 5 | Technology | 9.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Pfizer
PFE
$141B
| $2.3M | 0.68% |
71,463
-975
| -1% | -$31.3K |
|
27
Procter & Gamble
PG
$368B
| $1.94M | 0.57% |
24,078
-75
| -0.3% | -$6.04K |
|
|
COL
28
DELISTED
Rockwell Collins
COL
| $1.83M | 0.54% |
22,977
-300
| -1% | -$23.9K |
|
29
RTX Corp
RTX
$212B
| $1.51M | 0.45% |
12,942
-56
| -0.4% | -$6.55K |
|
30
Johnson & Johnson
JNJ
$427B
| $1.34M | 0.4% |
13,614
-150
| -1% | -$14.7K |
|
31
PepsiCo
PEP
$204B
| $1.11M | 0.33% |
13,230
-485
| -4% | -$40.5K |
|
|
CST
32
DELISTED
CST Brands, Inc.
CST
| $1.02M | 0.3% |
32,547
-1,004
| -3% | -$31.3K |
|
33
GE Aerospace
GE
$292B
| $951K | 0.28% |
36,722
-150
| -0.4% | -$3.89K |
|
34
IBM
IBM
$227B
| $877K | 0.26% |
4,554
-225
| -5% | -$43.3K |
|
35
Target
TGT
$43.6B
| $835K | 0.25% |
13,802
| – | – |
|
|
RDS.A
36
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $790K | 0.23% |
10,810
| – | – |
|
37
Clorox
CLX
$14.5B
| $761K | 0.23% |
8,646
| – | – |
|
38
Sempra
SRE
$53.9B
| $733K | 0.22% |
7,580
| – | – |
|
39
Genuine Parts
GPC
$19.4B
| $559K | 0.17% |
6,440
-70
| -1% | -$6.08K |
|
40
Novartis
NVS
$245B
| $490K | 0.15% |
5,759
| – | – |
|
41
Abbott
ABT
$231B
| $486K | 0.14% |
12,609
| – | – |
|
42
Bristol-Myers Squibb
BMY
$96B
| $481K | 0.14% |
9,252
-25
| -0.3% | -$1.3K |
|
43
3M
MMM
$82.8B
| $436K | 0.13% |
3,215
| – | – |
|
44
Berkshire Hathaway Class B
BRK.B
$1.09T
| $396K | 0.12% |
3,168
| – | – |
|
45
Coca-Cola
KO
$297B
| $391K | 0.12% |
10,118
| – | – |
|
46
AbbVie
ABBV
$372B
| $316K | 0.09% |
6,155
| – | – |
|
47
Marsh & McLennan
MMC
$101B
| $306K | 0.09% |
6,200
| – | – |
|
|
MON
48
DELISTED
Monsanto Co
MON
| $287K | 0.09% |
2,523
| – | – |
|
49
GSK
GSK
$79.9B
| $264K | 0.08% |
4,934
| – | – |
|
50
Caterpillar
CAT
$196B
| $255K | 0.08% |
2,565
| – | – |
|